|
Promising Early Evidence Of The Superior Benefits Of Drug Therapy …
Science Daily (press release) - 22 hours ago Ranibizumab was approved by the US Food and Drug Administration for the treatment of patients with wet age related macular degeneration in June 2006. |
While coverage of Lucentis to treat the wet form of age related macular degeneration has been recommended for UK residents by the National Institute of Clinical Instutute (NICE), people are still being denied treatment under the old criteria. Final decision on who should receive Lucentis treatment for free is expected in the next few months,
|
Acucela Presents Preclinical Data from Retinopathy Study …
Centre Daily Times, PA - 8 hours ago “There are many greatly unmet medical needs in ophthalmology, including retinopathy of prematurity and age-related macular degeneration (AMD). … |
 The Tech Herald |
Gene therapy may alleviate blindness, study shows
CTV.ca, Canada - Apr 28, 2008 Researchers hope that this gene therapy could one day treat other debilitating eye diseases, such as macular degeneration. Canadians looking for more … Gene Therapy Provides Vision to People who Were Nearly Blind PR Newswire (press release) all 13 news articles |
|
QLT reports $10.5-million loss
Vancouver Sun, Canada - Apr 26, 2008 In its first quarter, QLT sold $36.5 million US worth of the macular-degeneration blindness treatment, Visudyne, down 40 per cent from the same quarter a … |
